Page 40 - Program Highlights News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Toronto, Ontario–(Newsfile Corp. – May 25, 2021) –   C3 Metals Inc. (TSXV: CCCM) (“C3 Metals” or the “Company”) is pleased to announce first assay results from its drill program at the Jasperoide Copper-Gold Project in southern Peru. Drilling commenced in February in the southern Montaña de Cobre Zone with 15 holes now completed on two section lines for a total of 3,647m. Results from seven holes on the first drill section intersected broad zones of high-grade copper-gold mineralization within a larger low-moderate grade envelope. The drill program will now proceed to its plan...

C3 Metals Inc.: C3 Metals Confirms High Grade Cu-Au Mineralization at Jasperoide Project, Peru Toronto, Ontario--(Newsfile Corp. - May 25, 2021) - C3 Metals Inc. (TSXV: CCCM) ("C3 Metals" or the "Company") is pleased to announce first assay results from its drill program at the Jasperoide Copper-Gold Project in southern Peru. Drilling commenced in February in the southern Montaña de Cobre Zone with 15 holes now completed on two section lines for a total of 3,647m. Results from seven holes on the first drill section intersected broad zones of high-grade copper-gold mineralization within a lar...

Bellerophon Provides Clinical Program Update and Reports First Quarter 2021 Financial Results WARREN, N.J., May 11, 2021 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the first quarter ended March 31, 2021. “Bellerophon remains focused on advancing its INOpulse® inhaled nitric oxide therapy in multiple high-value areas of unmet need as expeditiously a...

Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates Read full article Oops! SARS-CoV-2 Variant Booster Program Update : Single booster dose of 50 µg of mRNA-1273 or mRNA-1273.351 increased neutralizing titers against SARS-CoV-2 and two Variants of Concern (B.1.351, P.1) in previously vaccinated clinical trial participants TeenCOVE Study Update : Initial analysis of the Phase 2/3 TeenCOVE study of mRNA-1273 showed vaccine efficacy against COVID-19 of 96%; mRNA-1273 was generally well tolerated with no serious safety concerns identified to date 2021 a...

Article content Results of the Drill Program expected to support original target of 1.2 – 1.6 million ounces at the Serra Alta Deposit New Mineral Resource Estimate targeted for late June and new Preliminary Economic Assessment for end of July We apologize, but this video has failed to load. Try refreshing your browser. Cerrado Gold Reports Successful Completion of Its Phase I Drill Program at Its Monte Do Carmo Project in Brazil Back to video Toronto, Ontario–(Newsfile Corp. – April 22, 2021) – Cerrado Gold Inc. (TSXV: CERT) (“Cerrado” or the “Company”) is pleased to anno...